Unique ID issued by UMIN | UMIN000013663 |
---|---|
Receipt number | R000015376 |
Scientific Title | The randomized controlled crossover clinical trial of Red Koji (Red Mold Rice) in the serum lipid-improvement with dietary therapy for prevention of atherosclerosis |
Date of disclosure of the study information | 2014/04/08 |
Last modified on | 2020/10/12 12:12:40 |
The randomized controlled crossover clinical trial of Red Koji (Red Mold Rice) in the serum lipid-improvement with dietary therapy for prevention of atherosclerosis
The randomized controlled crossover clinical trial of Red Koji (Red Mold Rice) with dietary therapy
The randomized controlled crossover clinical trial of Red Koji (Red Mold Rice) in the serum lipid-improvement with dietary therapy for prevention of atherosclerosis
The randomized controlled crossover clinical trial of Red Koji (Red Mold Rice) with dietary therapy
Japan |
Dyslipidemia
Endocrinology and Metabolism |
Others
NO
Examine the serum lipid improving effect as well as safety of proper use of Red Koji as a dietary supplement under control of medical management.
Efficacy
Confirmatory
Pragmatic
Not applicable
Change of LDL-C from the baseline to 4 and 8 weeks with Red Koji
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
NO
2
Treatment
Food |
Dietary therapy+Red Koji ->(washout period) -> Dietary therapy
Dietary therapy -> (washout period) -> Dietary therapy+Red Koji
20 | years-old | <= |
80 | years-old | > |
Male and Female
1)People with LDL-cholesterol level of 140 and over mg/dL without the past of a coronary artery disease
2)patients under an enforcement schedule or enforcement of dietary therapy for hypercholesterolemia
3)Age >=20 years, <80 years (Male and Female)
4)A consent form for participating in this study is submitted
1)Patients with familial hypercholesterolemia or with LDL-cholesterol level of 180 and over mg/dL
2)People with rice allergy, and people who have resistance in eating rice
3)Patients taking statin drugs within 4 weeks (or Probucol within 8 weeks) in the past
4)Patients with type 1 diabetes or diabetic patients with HbA1c level of over 8%
5)Patients with sever diseases other than diabetes, such as liver disease, a renal disease, and cardiac disease
6)Patients with the past, such as a food allergy, idiosyncrasy, and alcoholism
7)People who participated in other clinical trials within the past three months before the start of this clinical trial, or who have participated in other clinical trials at the start of this clinical trial
8)Patients who are pregnant, breastfeeding or intention to becoming pregnant
9)Patients whose LDL-cholesterol level became less than 140 mg/dL by dietary therapy of period I or patients with TG level of 400 and over mg/dL
10)Patients judged unsuitable by the investigator.
16
1st name | |
Middle name | |
Last name | Hiroshi Mabuchi |
Kanazawa University Graduate School of Medical Sciences
Department of Lipidology
13-1 Takaramachi, Knazawa, 920-8640
076-265-2000
mabuchi@med.kanazawa-u.ac.jp
1st name | |
Middle name | |
Last name | Atsushi Nohara |
Kanazawa University Graduate School of Medical Sciences
Department of Lipidology
13-1 Takaramachi, Knazawa, 920-8640
076-265-2000
a-nohara@med.kanazawa-u.ac.jp
Kanazawa University Graduate School of Medical Sciences
Kanazawa University Graduate School of Medical Sciences
Self funding
NO
2014 | Year | 04 | Month | 08 | Day |
Unpublished
Main results already published
2014 | Year | 02 | Month | 25 | Day |
2014 | Year | 03 | Month | 27 | Day |
2014 | Year | 04 | Month | 17 | Day |
2015 | Year | 10 | Month | 25 | Day |
2014 | Year | 04 | Month | 07 | Day |
2020 | Year | 10 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015376